Scholars Central

ArticlePublished 11 Jan 2024

Effect of Triple Therapy with Lactobacillus acidophilus Tablets on Intestinal Flora in Chronic Helicobacter pylori Infected Atrophic Gastritis

Authors: Weiwei Dai, Cuiyun Cao, J. H. Weng, Baohong Xu

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

To evaluate the effects of Lactobacillus acidophilus tablets based on quadruple therapy on intestinal flora and inflammatory response in patients with Helicobacter pylori-infected chronic atrophic gastritis is the objective of the study. The clinical data of Helicobacter pylori-infected patients with Helicobacter pylori-infected chronic atrophic gastritis were analyzed retrospectively and 90 patients who met the criteria of inclusion and exclusion were selected as subjects. The control group was treated with conventional quadruple therapy and the observation group was treated with compound Lactobacillus acidophilus tablets combined with quadruple therapy. The intestinal flora and inflammation of the patients were compared. The efficacy of 82 % (41/50) and 96 % (p<0.05) were significantly higher in the post-treatment observation group than in the control group; the area of gastric lesion (0.85±0.17) was significantly lower than in the control group (p<0.05) and the digestive system symptoms score (3.23±1.13) was significantly lower than in the control group (6.67 %). Gastrointestinal function score (4.63±1.39) and Helicobacter pylori eradication rate (47/50) were significantly higher (94 %) in the observation group than in the control group, p<0.05; tumor necrosis factor alpha, (23.39±6.20 µg/ml) and interleukin-6 (15.39±6.41 µg/ml) were significantly lower than that in the control group and gastrin level (1.78±0.19 nmol/l) was significantly higher. Compound Lactobacillus acidophilus tablets based on quadruple therapy for the treatment of Helicobacter pylori-infected chronic atrophic gastritis can well eradicate Helicobacter pylori, control intestinal inflammation, improve intestinal flora and reduce clinical symptoms and signs of patients.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Indian Journal of Pharmaceutical Sciences.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalIndian Journal of Pharmaceutical Sciences
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Weiwei Dai”
  • BylineArticles whose byline prints “Cuiyun Cao”
  • BylineArticles whose byline prints “J. H. Weng”
  • BylineArticles whose byline prints “Baohong Xu”